These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


547 related items for PubMed ID: 8456048

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The use of clonidine in detoxification from opiates.
    Kleber HD, Gold MS, Riordan CE.
    Bull Narc; 1980; 32(2):1-10. PubMed ID: 6907020
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Opiate withdrawal using lofexidine, a clonidine analogue with fewer side effects.
    Washton AM, Resnick RB, Geyer G.
    J Clin Psychiatry; 1983 Sep; 44(9):335-7. PubMed ID: 6355070
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Endorphin-locus coeruleus connection mediates opiate action and withdrawal.
    Gold MS, Byck R, Sweeney DR, Kleber HD.
    Biomedicine; 1979 Feb; 30(1):1-4. PubMed ID: 223678
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.
    Umbricht A, Hoover DR, Tucker MJ, Leslie JM, Chaisson RE, Preston KL.
    Drug Alcohol Depend; 2003 Apr 01; 69(3):263-72. PubMed ID: 12633912
    [Abstract] [Full Text] [Related]

  • 31. Clonidine and opiate receptor antagonists in the treatment of heroin addiction.
    Gerra G, Marcato A, Caccavari R, Fontanesi B, Delsignore R, Fertonani G, Avanzini P, Rustichelli P, Passeri M.
    J Subst Abuse Treat; 1995 Apr 01; 12(1):35-41. PubMed ID: 7752296
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Treating opioid dependence. Growing implications for primary care.
    Krantz MJ, Mehler PS.
    Arch Intern Med; 2004 Feb 09; 164(3):277-88. PubMed ID: 14769623
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Clonidine hydrochloride: a nonopiate treatment for opiate withdrawal.
    Washton AM, Resnick RB, Rawson RA.
    NIDA Res Monogr; 1979 Feb 09; 27():233-9. PubMed ID: 121339
    [No Abstract] [Full Text] [Related]

  • 39. The role of the National Institute on Drug Abuse in the development of naltrexone.
    Ginzburg HM, Glass WJ.
    J Clin Psychiatry; 1984 Sep 09; 45(9 Pt 2):4-6. PubMed ID: 6088469
    [Abstract] [Full Text] [Related]

  • 40. 24-Hour opiate detoxification and antagonist induction at home--the 'Asturian method': a report on 1368 procedures.
    Carreño JE, Bobes J, Brewer C, Alvarez CE, San Narciso GI, Bascarán MT, Sánchez del Río J.
    Addict Biol; 2002 Apr 09; 7(2):243-50. PubMed ID: 12006220
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 28.